NewAmsterdam Pharma Co N.V. (NAMSW) › Shareholders' EquityNewAmsterdam Pharma Co N.V. (NAMSW) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -$73.03M2021: -$113.82M2022: $430.07M2023: $288.39M2024: $757.50M2025: $683.43M$683.43M2020Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$683.43M-9.8%2024$757.50M+162.7%2023$288.39M-32.9%2022$430.07M+477.9%2021-$113.82M-55.8%2020-$73.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share